About: C reactive protein level may predict the risk of COVID-19 aggravation

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: C reactive protein level may predict the risk of COVID-19 aggravation Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	C reactive protein level may predict the risk of COVID-19 aggravation
Creator	Wu, Chao Li, Yiming Zhang, Quan Lv, Jianlei Zhong, Yanjun Yu, Bo Li, Tiao Wang, Guyi Wu, Chenfang Wu, Guobao Zhang, Siye
Source	Medline; PMC
abstract	BACKGROUND: Clinical findings indicated that a fraction of Corona Virus Disease 2019 (COVID-19) patients diagnosed as mild early may progress to severe cases. However, it is difficult to distinguish these patients in the early stage. The present study was to describe the clinical characteristics of these patients, analyze related factors and explore predictive markers of the disease aggravation. METHODS: Clinical and laboratory data of non-severe adult COVID-19 patients in Changsha, China, were collected and analyzed on admission. A logistic regression model was adopted to analyze the association between the disease aggravation and related factors. Receiver operating characteristic curve (ROC) was utilized to analyze the prognostic ability of C-reactive protein (CRP). RESULTS: About 7.7% (16/209) non-severe adult COVID-19 patients progressed to severe cases after admission. Compared with non-severe patients, the aggravated patients had much higher levels of CRP (median, 43.8 mg/L [range: 12.3-101.9] vs 12.1 mg/L [range: 0.1-91.4]; P = 0.000). The regression analysis showed CRP was significantly associated with the aggravation of non-severe COVID-19 patients, with an area under the curves (AUC) of 0.844 (95% CI, 0.761 - 0.926) and the optimal threshold value of 26.9 mg/L. CONCLUSIONS: CRP could be a valuable marker to anticipate the possibility of aggravation of non-severe adult COVID-19 patients, with the optimal threshold value of 26.9 mg/L.
has issue date	2020-04-29(xsd:dateTime)
bibo:doi	10.1093/ofid/ofaa153
bibo:pmid	32455147
has license	cc-by-nc-nd
sha1sum (hex)	3ce7ea950f08e9cb13b125f0c240e36d5ef5e989
schema:url	https://doi.org/10.1093/ofid/ofaa153
resource representing a document's title	C reactive protein level may predict the risk of COVID-19 aggravation
has PubMed Central identifier	PMC7197542
has PubMed identifier	32455147
schema:publication	Open Forum Infect Dis
resource representing a document's body	covid:3ce7ea950f08e9cb13b125f0c240e36d5ef5e989#body_text
is schema:about of	named entity 'BACKGROUND' named entity 'STUDY' named entity 'CRP' named entity 'COVID' named entity 'underlying diseases' named entity 'COVID' named entity 'multi-center studies' named entity 'medical records' named entity 'medical history' named entity 'logistic regression' named entity 'clinical characteristics' named entity 'area under the curve' named entity 'health care' named entity 'reduce the spread' named entity 'COVID' named entity 'SPSS' named entity 'median age' named entity 'CRP' named entity 'PaO2/FiO2' named entity 'China' named entity 'respiratory function' named entity 'Public Health' named entity 'SARS-CoV-2' named entity 'Xiangya' named entity 'clinical characteristics' named entity 'CRP' named entity 'intensive care unit' named entity 'comorbidities' named entity 'ROC curve' named entity 'liver' named entity 'inflammation' named entity 'oxygen saturation' named entity 'logistic regression' named entity 'symptom' named entity 'CRP' named entity 'China' named entity 'mechanical ventilation' named entity 'blood oxygen saturation' named entity 'coronavirus 2' named entity 'Corona Virus Disease' named entity 'health care workers' named entity 'risk factors' named entity 'COVID' named entity 'IBM' named entity 'Fisher's exact test' named entity 'CRP' named entity 'China' named entity 'COVID-19' named entity 'compensatory effect' named entity 'small numbers' named entity 'virus' named entity 'rescue therapy' named entity 'China' named entity 'median age' named entity 'isolation ward' named entity 'Changsha' named entity 'bacterial infections' named entity 'univariate analysis' named entity 'probability' named entity 'shortness of breath' named entity 'South Korea' named entity 'clinically relevant' named entity 'COVID-19' named entity 'clinical features' named entity 'CRP' named entity 'demographic data' named entity 'Kaplan-Meier' named entity 'viral infections' named entity 'Mann-Whitney' named entity 'China' named entity 'COVID'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software